Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancer

Journal:

Journal of Infectious Diseases

Published:

2026-01-20

DOI:

10.1093/infdis/jiag038

Affiliations:

3

Authors:

6

Go to article

Institutions	Authors	Share
NIH National Cancer Institute (NCI), United States of America (USA)	4.000000	0.67
National Institute of Standards and Technology (NIST), United States of America (USA)	1.000000	0.17
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.17

Interested in Epidemiology?